$TMHC
Taylor Morrison Home Corp Stock $tmhc

$tmhc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024019320 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$1.991B	$1.700B
YoY Change	-3.37%	2.28%
Cost Of Revenue	$1.519B	$1.283B
YoY Change	-2.7%	1.63%
Gross Profit	$472.3M	$416.8M
YoY Change	-5.48%	4.32%
Gross Profit Margin	23.72%	24.52%
Selling, General & Admin	$196.7M	$170.2M
YoY Change	7.11%	7.01%
% of Gross Profit	41.66%	40.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.33M	$10.25M
YoY Change	53.31%	44.63%
% of Gross Profit	2.4%	2.46%
Operating Expenses	$196.7M	$170.8M
YoY Change	2.34%	7.38%
Operating Profit	$275.6M	$246.1M
YoY Change	-10.38%	2.3%
Interest Expense	-$4.087M	$2.794M
YoY Change	-149.21%	-8.09%
% of Operating Profit	-1.48%	1.14%
Other Income/Expense, Net	-$10.96M	-$552.0K
YoY Change	219.74%	-109.29%
Pretax Income	$267.2M	$248.9M
YoY Change	-15.37%	0.19%
Income Tax	$67.30M	$57.72M
% Of Pretax Income	25.19%	23.19%
Net Earnings	$199.5M	$190.3M
YoY Change	-14.98%	-0.41%
Net Earnings / Revenue	10.02%	11.19%
Basic Earnings Per Share	$1.89	$1.79
Diluted Earnings Per Share	$1.86	$1.75
COMMON SHARES
Basic Shares Outstanding	105.8M shares	106.4M
Diluted Shares Outstanding	107.2M shares	108.6M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$246.8M	$554.3M
YoY Change	-79.89%	-36.85%
Cash & Equivalents	$246.8M	$554.3M
Short-Term Investments
Other Short-Term Assets	$330.1M	$287.5M
YoY Change	26.44%	27.56%
Inventory	$4.313B	$5.985B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$7.078B	$7.017B
YoY Change	2.41%	5.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$316.7M	$373.6M
YoY Change	4.03%	75.11%
Goodwill	$663.2M	$663.2M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$586.1M	$569.0M
YoY Change	13.98%	8.83%
Other Assets	$382.8M	$287.6M
YoY Change	7.7%	10.36%
Total Long-Term Assets	$2.021B	$1.893B
YoY Change	9.99%	8.56%
TOTAL ASSETS
Total Short-Term Assets	$7.078B	$7.017B
Total Long-Term Assets	$2.021B	$1.893B
Total Assets	$9.099B	$8.910B
YoY Change	4.0%	6.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$310.7M	$276.1M
YoY Change	10.35%	11.38%
Accrued Expenses	$600.6M	$494.5M
YoY Change	20.02%	6.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.260B	$1.174B
YoY Change	8.12%	3.91%
LONG-TERM LIABILITIES
Long-Term Debt	$2.150B	$2.093B
YoY Change	-10.18%	-9.05%
Other Long-Term Liabilities	$162.1M	$216.6M
YoY Change	72.17%	121.24%
Total Long-Term Liabilities	$2.312B	$2.310B
YoY Change	-7.06%	-3.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.260B	$1.174B
Total Long-Term Liabilities	$2.312B	$2.310B
Total Liabilities	$3.573B	$3.502B
YoY Change	-2.67%	-0.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.527B	$5.408B
YoY Change
Total Liabilities & Shareholders Equity	$9.099B	$8.910B
YoY Change	4.0%	6.38%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$199.5M	$190.3M
YoY Change	-14.98%	-0.41%
Depreciation, Depletion And Amortization	$11.33M	$10.25M
YoY Change	53.31%	44.63%
Cash From Operating Activities	-$233.3M	-$130.7M
YoY Change	-189.86%	-137.63%
INVESTING ACTIVITIES
Capital Expenditures	$8.330M	$9.111M
YoY Change	15.09%	-34.01%
Acquisitions
YoY Change
Other Investing Activities	-$15.93M	-$23.94M
YoY Change	22.44%	122.19%
Cash From Investing Activities	-$24.26M	-$33.05M
YoY Change	19.81%	34.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-51.04M	-85.92M
YoY Change	-148.99%	-47.95%
NET CHANGE
Cash From Operating Activities	-233.3M	-130.7M
Cash From Investing Activities	-24.26M	-33.05M
Cash From Financing Activities	-51.04M	-85.92M
Net Change In Cash	-308.6M	-249.7M
YoY Change	-189.82%	-258.24%
FREE CASH FLOW
Cash From Operating Activities	-$233.3M	-$130.7M
Capital Expenditures	$8.330M	$9.111M
Free Cash Flow	-$241.7M	-$139.8M
YoY Change	-195.73%	-141.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1699752000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1661857000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1282907000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1262291000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	416845000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	399566000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	102600000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	92760000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	67564000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66261000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2751000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1929000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	43000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1111000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-595000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4834000	usd
CY2024Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	248880000	usd
CY2023Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	248419000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57719000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57191000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	191161000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	191228000	usd
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	891000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	177000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	190270000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	191051000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106457000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108429000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108564000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110053000	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5332286000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	191161000	usd
CY2024Q1	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	-10856000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	91649000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	5483000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	257000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5426168000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4646859000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	191228000	usd
CY2023Q1	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	4493000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3568000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	7533000	usd
CY2023Q1	tmhc	Noncontrolling Interest Increase Decrease From Contributions Distributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseDecreaseFromContributionsDistributionsToNoncontrollingInterestHolders	1000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4846546000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13500000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	191161000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	191228000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2751000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1929000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5483000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7533000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2897000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	847000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10250000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7087000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	5903000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7144000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	741000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	868000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	363923000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-51596000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	35783000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-190202000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	31570000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1993000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22133000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-112097000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	45848000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2977000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-130737000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	347449000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9111000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13807000	usd
CY2024Q1	tmhc	Distributions Of Capital From Unconsolidated Entities DistributionsOfCapitalFromUnconsolidatedEntities	0	usd
CY2023Q1	tmhc	Distributions Of Capital From Unconsolidated Entities DistributionsOfCapitalFromUnconsolidatedEntities	350000	usd
CY2024Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	23936000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	11123000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33047000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24580000	usd
CY2024Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	2425000	usd
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	11544000	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	7377000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	713090000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	634404000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	683380000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	794142000	usd
CY2024Q1	tmhc	Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet	-10856000	usd
CY2023Q1	tmhc	Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet	4493000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1327000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1305000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	91649000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3568000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	257000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85923000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-165070000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-249707000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	157799000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807099000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	726635000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	557392000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	884434000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-120000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1943000	usd
CY2024Q1	tmhc	Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts	-100453000	usd
CY2023Q1	tmhc	Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts	-39865000	usd
CY2024Q1	tmhc	Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned	71811000	usd
CY2023Q1	tmhc	Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned	-21676000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Use of Estimates</span><span style="color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> — The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited Condensed consolidated financial statements and accompanying notes. Significant estimates include real estate development costs to complete, valuation of real estate, valuation of goodwill, valuation of estimated development liabilities, valuation of equity awards, valuation allowance on deferred tax assets, and reserves for warranty and self-insured risks. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2024Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	190270000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	191051000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106457000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108429000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108564000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110053000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2024Q1	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	4076312000	usd
CY2023Q4	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	3855534000	usd
CY2024Q1	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	46312000	usd
CY2023Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	29317000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4122624000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	3884851000	usd
CY2024Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1542078000	usd
CY2023Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1414528000	usd
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	177222000	usd
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	174449000	usd
CY2024Q1	tmhc	Inventory Real Estate Owned InventoryRealEstateOwned	5841924000	usd
CY2023Q4	tmhc	Inventory Real Estate Owned InventoryRealEstateOwned	5473828000	usd
CY2024Q1	tmhc	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	143429000	usd
CY2023Q4	tmhc	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	71618000	usd
CY2024Q1	us-gaap	Inventory Real Estate InventoryRealEstate	5985353000	usd
CY2023Q4	us-gaap	Inventory Real Estate InventoryRealEstate	5545446000	usd
CY2024Q1	tmhc	Number Of Lots Owned NumberOfLotsOwned	35206	lot
CY2023Q4	tmhc	Number Of Lots Owned NumberOfLotsOwned	34077	lot
CY2024Q1	tmhc	Number Of Controlled Lots NumberOfControlledLots	38976	lot
CY2023Q4	tmhc	Number Of Controlled Lots NumberOfControlledLots	38285	lot
CY2024Q1	tmhc	Number Of Owned And Controlled Lots NumberOfOwnedAndControlledLots	74182	lot
CY2023Q4	tmhc	Number Of Owned And Controlled Lots NumberOfOwnedAndControlledLots	72362	lot
CY2024Q1	tmhc	Number Of Homes In Inventory NumberOfHomesInInventory	8578	home
CY2023Q4	tmhc	Number Of Homes In Inventory NumberOfHomesInInventory	7867	home
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	174449000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	190123000	usd
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	26398000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	34133000	usd
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	23625000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	27649000	usd
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	177222000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	196607000	usd
CY2024Q1	tmhc	Real Estate Land And Land Development Costs RealEstateLandAndLandDevelopmentCosts	45723000	usd
CY2023Q4	tmhc	Real Estate Land And Land Development Costs RealEstateLandAndLandDevelopmentCosts	46114000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	77393000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	149095000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	186948000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	184448000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	26039000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	31042000	usd
CY2024Q1	tmhc	Accrued Property And Sales Tax AccruedPropertyAndSalesTax	29442000	usd
CY2023Q4	tmhc	Accrued Property And Sales Tax AccruedPropertyAndSalesTax	30887000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	93550000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	107488000	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	459095000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	549074000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	184448000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	161675000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	20666000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	14447000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	21193000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20508000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	3027000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	2608000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	186948000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	158222000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2101434000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	7935000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	2093499000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2025477000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8375000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2017102000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2024Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	183174000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	360000000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	153464000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	360000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.230
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	494489000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	279138000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	91649000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3568000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	402840000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	275570000	usd
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1491485	shares
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	109325	shares
CY2022Q3	tmhc	Percentage Of Excise Tax On Net Repurchase Of Stock PercentageOfExciseTaxOnNetRepurchaseOfStock	0.01
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5483000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7533000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	45200000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	26500000	usd
CY2024Q1	tmhc	Number Of Reportable Segments Included In Operating Component NumberOfReportableSegmentsIncludedInOperatingComponent	3	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1699752000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	416845000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170164000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2751000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-552000	usd
CY2024Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	248880000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1661857000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	399566000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	159021000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1929000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5945000	usd
CY2023Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	248419000	usd
CY2024Q1	tmhc	Real Estate Inventory And Land Deposits RealEstateInventoryAndLandDeposits	6184396000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	369982000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	2355965000	usd
CY2024Q1	us-gaap	Assets Assets	8910343000	usd
CY2023Q4	tmhc	Real Estate Inventory And Land Deposits RealEstateInventoryAndLandDeposits	5748663000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	346192000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2577232000	usd
CY2023Q4	us-gaap	Assets Assets	8672087000	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1300000000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1300000000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	23200000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	26200000	usd
CY2023Q4	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	64700000	usd
CY2024Q1	tmhc	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	81100000	usd
CY2023Q4	tmhc	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	85000000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	5900000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	7100000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2834000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3566000	usd
CY2024Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	291800000	usd
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	242600000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-019320-index-headers.html	Edgar Link	pending
0001628280-24-019320-index.html	Edgar Link	pending
0001628280-24-019320.txt	Edgar Link	pending
0001628280-24-019320-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmhc-20240331.htm	Edgar Link	pending
tmhc-20240331.xsd	Edgar Link	pending
tmhc-20240331xexx311.htm	Edgar Link	pending
tmhc-20240331xexx312.htm	Edgar Link	pending
tmhc-20240331xexx321.htm	Edgar Link	pending
tmhc-20240331xexx322.htm	Edgar Link	pending
tmhc-20240331_def.xml	Edgar Link	unprocessable
tmhc-20240331_lab.xml	Edgar Link	unprocessable
tmhc-20240331_pre.xml	Edgar Link	unprocessable
tmhc-20240331_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tmhc-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMHC
Taylor Morrison Home Corp Stock $tmhc

2024 Q2 Form 10-Q Financial Statement

#000162828024019320 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMHC Taylor Morrison Home Corp Stock $tmhc

2024 Q2 Form 10-Q Financial Statement

#000162828024019320 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMHC
Taylor Morrison Home Corp Stock $tmhc